Clinical Trials 365

Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial https://lnkd.in/dxEpGvYz #pharmaindustry #Alzheimer #clinicaltrials Anavex Life Sciences Juan Carlos Lopez-Talavera, MD, PhD Christopher Missling, PhD

Qurient Launches Clinical Trial for Acute Myeloid Leukemia Treatment with Adrixetinib (Q702) https://lnkd.in/e5AaZJxc #clinicaltrials #pharmaindustry #leukemia Qurient, Inc. Kiyean Nam

Firefly Neuroscience : use of its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder https://lnkd.in/dbaVCei4 #clinicaltrials #depression #pharmaindustry Firefly Neuroscience Jon Olsen Steve Butts Walt Duffy MD

Pfizer’s TALZENNA? in Combination with XTANDI? Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial - First and only PARP inhibitor plus ARPI combination to demonstrate statistically significant overall survival (OS) benefit in patients with metastatic castration-resistant prostate cancer (mCRPC) https://lnkd.in/dtwiAnCT #clinicaltrials #cancer #oncology Pfizer Roger Dansey

UNION therapeutics announce results from the ADESOS Phase 2b study in atopic dermatitis confirming the potential of orismilast as a first-in-class safe and efficacious oral treatment https://lnkd.in/d5BBSCCA #clinicaltrials #pharmaindustry #dermatitis UNION therapeutics A/S Kim Domela Kj?ller

Positive topline results for NUBEQA? (darolutamide) from Phase III trial in men with metastatic hormone-sensitive prostate cancer (mHSPC) https://lnkd.in/drSrkuUU #pharmaindustry #prostatecancer #clinicaltrial Bayer Christian Rommel

Genentech : Update on Phase II/III SKYSCRAPER-06 Study in Metastatic Non-Squamous Non-Small Cell Lung Cancer https://lnkd.in/dT5GhUKx #clinicaltrials #oncology #immunotherapies Genentech

Epsilogen : CTA approval for Phase Ib trial of MOv18 IgE in platinum-resistant ovarian cancer https://lnkd.in/dKX-YKsW #clinicaltrials #ovariancancer #antibodies Epsilogen Ltd Tim Wilson Simon Conway

Oculis : Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy https://lnkd.in/d7MAw2zR #clinicaltrials #pharmaindustry #opthalmology Oculis Riad SHERIF Eric Donnenfeld Christophe Baudouin Sylvia Cheung

Tiziana Life Sciences : Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab (anti-CD3 mAb) https://lnkd.in/dq4a2JK8 #multiplesclerosis #clinicaltrials #pharmaindustry Tiziana Life Sciences Tarun Singhal, MBBS, MD Irina Koffler